| http://dbpedia.org/ontology/abstract
|
Saridegib, also known as IPI-926, is an ex … Saridegib, also known as IPI-926, is an experimental drug candidate undergoing clinical trials for the treatment of various types of cancer, including hard-to-treat hematologic malignancies such as myelofibrosis and ligand-dependent tumors such as chondrosarcoma. IPI-926 exhibits its pharmacological effect by inhibition of the G protein-coupled receptor smoothened, a component of the hedgehog signaling pathway. Chemically, it is a semi-synthetic derivative of the alkaloid cyclopamine. The process begins with cyclopamine extracted from harvested Veratrum californicum which is taken through a series of alterations resulting in an analogue of the natural product cyclopamine, making IPI-926 the only compound in development/testing that is not fully synthetic. Saridegib is a member of a class of anti-cancer compounds known as hedgehog pathway inhibitors.unds known as hedgehog pathway inhibitors.
|
| http://dbpedia.org/ontology/alternativeName
|
saridegib
|
| http://dbpedia.org/ontology/iupacName
|
N-[(5βH)-5,6-Dihydro-17,23β-epoxy-16a-homoveratraman-3α-yl]methanesulfonamide
, N-[(2S,3R,3′R,3aS,4′aR,6S,6′aR,6′bS,7aR,12′aS,12′bS)-3,6,11′,12′b-Tetramethyl-2′,3′,3a,4,4′,4′a,5,5′,6,6′,6′a,6′b,7,7′,7a,8′,10′,12′,12′a,12′b-icosahydro-1′H,3H-spiro[furo[3,2-b]pyridine-2,9′-naphtho[2,1-a]azulen]-3′-yl]methanesulfonamide
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Saridegib.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
32466511
|
| http://dbpedia.org/ontology/wikiPageLength
|
4359
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1031001819
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Myelofibrosis +
, http://dbpedia.org/resource/Chondrosarcoma +
, http://dbpedia.org/resource/Category:Sulfonamides +
, http://dbpedia.org/resource/Category:Spiro_compounds +
, http://dbpedia.org/resource/Veratrum_californicum +
, http://dbpedia.org/resource/Alkaloid +
, http://dbpedia.org/resource/Hedgehog_pathway_inhibitors +
, http://dbpedia.org/resource/Smoothened +
, http://dbpedia.org/resource/Category:Jervines +
, http://dbpedia.org/resource/G_protein-coupled_receptor +
, http://dbpedia.org/resource/Category:Teratogens +
, http://dbpedia.org/resource/Hedgehog_signaling_pathway +
, http://dbpedia.org/resource/Cyclopamine +
, http://dbpedia.org/resource/Category:Experimental_cancer_drugs +
, http://dbpedia.org/resource/Derivative_%28chemistry%29 +
|
| http://dbpedia.org/property/imagefile
|
Saridegib.svg
|
| http://dbpedia.org/property/iupacname
|
N-[-5,6-Dihydro-17,23β-epoxy-16a-homoveratraman-3α-yl]methanesulfonamide
|
| http://dbpedia.org/property/othernames
|
saridegib
|
| http://dbpedia.org/property/pin
|
N-[-3,6,11′,12′b-Tetramethyl-2′,3′,3a,4,4′,4′a,5,5′,6,6′,6′a,6′b,7,7′,7a,8′,10′,12′,12′a,12′b-icosahydro-1′H,3H-spiro[furo[3,2-b]pyridine-2,9′-naphtho[2,1-a]azulen]-3′-yl]methanesulfonamide
|
| http://dbpedia.org/property/verifiedrevid
|
443867582
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Chembox_Identifiers +
, http://dbpedia.org/resource/Template:Chembox_Hazards +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Chembox_Properties +
, http://dbpedia.org/resource/Template:Chembox +
, http://dbpedia.org/resource/Template:Refimprove +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Chembox_Pharmacology +
, http://dbpedia.org/resource/Template:Cascite +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Teratogens +
, http://dbpedia.org/resource/Category:Spiro_compounds +
, http://dbpedia.org/resource/Category:Experimental_cancer_drugs +
, http://dbpedia.org/resource/Category:Sulfonamides +
, http://dbpedia.org/resource/Category:Jervines +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Candidate +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Saridegib?oldid=1031001819&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Saridegib.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Saridegib +
|
| owl:sameAs |
http://yago-knowledge.org/resource/Saridegib +
, http://sr.dbpedia.org/resource/IPI-926 +
, http://sh.dbpedia.org/resource/IPI-926 +
, https://global.dbpedia.org/id/YCoN +
, http://rdf.freebase.com/ns/m.0h1g57v +
, http://www.wikidata.org/entity/Q15426668 +
, http://dbpedia.org/resource/Saridegib +
|
| rdf:type |
http://dbpedia.org/class/yago/Antibacterial102716205 +
, http://www.wikidata.org/entity/Q11173 +
, http://dbpedia.org/class/yago/WikicatMolecularFormulas +
, http://dbpedia.org/class/yago/MolecularFormula106817173 +
, http://dbpedia.org/class/yago/BodyPart105220461 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/Formula106816935 +
, http://dbpedia.org/class/yago/Part109385911 +
, http://dbpedia.org/class/yago/Medicine103740161 +
, http://dbpedia.org/class/yago/Communication100033020 +
, http://dbpedia.org/class/yago/Structure105225602 +
, http://dbpedia.org/class/yago/Ligand115110307 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/ontology/ChemicalCompound +
, http://dbpedia.org/class/yago/Thing100002452 +
, http://dbpedia.org/class/yago/Agent114778436 +
, http://dbpedia.org/class/yago/CausalAgent100007347 +
, http://dbpedia.org/class/yago/Drug103247620 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/Receptor105608868 +
, http://dbpedia.org/class/yago/Substance100020090 +
, http://dbpedia.org/class/yago/Statement106722453 +
, http://dbpedia.org/class/yago/Message106598915 +
, http://dbpedia.org/class/yago/WikicatGProteinCoupledReceptors +
, http://dbpedia.org/class/yago/WikicatLigands +
, http://dbpedia.org/ontology/Person +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/WikicatSulfonamides +
, http://dbpedia.org/class/yago/SulfaDrug104352070 +
|
| rdfs:comment |
Saridegib, also known as IPI-926, is an ex … Saridegib, also known as IPI-926, is an experimental drug candidate undergoing clinical trials for the treatment of various types of cancer, including hard-to-treat hematologic malignancies such as myelofibrosis and ligand-dependent tumors such as chondrosarcoma. IPI-926 exhibits its pharmacological effect by inhibition of the G protein-coupled receptor smoothened, a component of the hedgehog signaling pathway. Chemically, it is a semi-synthetic derivative of the alkaloid cyclopamine. The process begins with cyclopamine extracted from harvested Veratrum californicum which is taken through a series of alterations resulting in an analogue of the natural product cyclopamine, making IPI-926 the only compound in development/testing that is not fully synthetic.pment/testing that is not fully synthetic.
|
| rdfs:label |
Saridegib
|
